These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

471 related articles for article (PubMed ID: 25546380)

  • 21. Liver transplantation significantly improves global functioning and cerebral processing.
    Ahluwalia V; Wade JB; White MB; Gilles HS; Heuman DM; Fuchs M; Gavis EA; Fagan A; Tinsley F; Ganapathy D; Thacker LR; Sterling RK; Stravitz RT; Puri P; Sanyal AJ; Siddiqui MS; Matherly S; Luketic V; Steinberg J; Moeller FG; Bajaj JS
    Liver Transpl; 2016 Oct; 22(10):1379-90. PubMed ID: 27339647
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extrapyramidal signs predict the development of overt hepatic encephalopathy in patients with liver cirrhosis.
    Compañy L; Zapater P; Pérez-Mateo M; Jover R
    Eur J Gastroenterol Hepatol; 2010 May; 22(5):519-25. PubMed ID: 20010298
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cerebral abnormalities in patients with cirrhosis detected by proton magnetic resonance spectroscopy and magnetic resonance imaging.
    Geissler A; Lock G; Fründ R; Held P; Hollerbach S; Andus T; Schölmerich J; Feuerbach S; Holstege A
    Hepatology; 1997 Jan; 25(1):48-54. PubMed ID: 8985263
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Probiotics prevent hepatic encephalopathy in patients with cirrhosis: a randomized controlled trial.
    Lunia MK; Sharma BC; Sharma P; Sachdeva S; Srivastava S
    Clin Gastroenterol Hepatol; 2014 Jun; 12(6):1003-8.e1. PubMed ID: 24246768
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sub-clinical hepatic encephalopathy in cirrhotic patients is not aggravated by sedation with propofol compared to midazolam: a randomized controlled study.
    Khamaysi I; William N; Olga A; Alex I; Vladimir M; Kamal D; Nimer A
    J Hepatol; 2011 Jan; 54(1):72-7. PubMed ID: 20934771
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Confounders in the detection of minimal hepatic encephalopathy: a neuropsychological and quantified EEG study.
    Campagna F; Montagnese S; Schiff S; Ruzzoli M; Biancardi A; Iannizzi P; Pujatti PL; Angeli P; Gatta A; Merkel C; Leandro G; Mapelli D; Amodio P
    Liver Int; 2015 May; 35(5):1524-32. PubMed ID: 25040245
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnosis of minimal hepatic encephalopathy in a tertiary care center from eastern Romania: validation of the psychometric hepatic encephalopathy score (PHES).
    Badea MA; Drug VL; Dranga M; Gavrilescu O; Stefanescu G; Popa I; Mihai C; Cijevschi-Prelipcean C
    Metab Brain Dis; 2016 Dec; 31(6):1463-1471. PubMed ID: 27461111
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Review article: the modern management of hepatic encephalopathy.
    Bajaj JS
    Aliment Pharmacol Ther; 2010 Mar; 31(5):537-47. PubMed ID: 20002027
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Auditory event-related cerebral potentials (P300) in hepatic encephalopathy--topographic distribution and correlation with clinical and psychometric assessment.
    Hollerbach S; Kullmann F; Fründ R; Lock G; Geissler A; Schölmerich J; Holstege A
    Hepatogastroenterology; 1997; 44(16):1002-12. PubMed ID: 9261590
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Minimal hepatic encephalopathy: a better diagnostic to improve prognostic].
    Ennaifer R; Cheikh M; Hefaiedh R; Romdhane H; Ben Nejma H; Hadj NB
    Presse Med; 2014 May; 43(5):e127-33. PubMed ID: 24703736
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Altered postural control and stability in cirrhotic patients with minimal hepatic encephalopathy correlate with cognitive deficits.
    Urios A; Mangas-Losada A; Gimenez-Garzó C; González-López O; Giner-Durán R; Serra MA; Noe E; Felipo V; Montoliu C
    Liver Int; 2017 Jul; 37(7):1013-1022. PubMed ID: 27988985
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of the most favoured methods for the diagnosis of hepatic encephalopathy in liver transplantation candidates.
    Goldbecker A; Weissenborn K; Hamidi Shahrezaei G; Afshar K; Rümke S; Barg-Hock H; Strassburg CP; Hecker H; Tryc AB
    Gut; 2013 Oct; 62(10):1497-504. PubMed ID: 23297006
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes in Cerebral Hemodynamics in Patients With Cirrhosis After Liver Transplantation.
    Macías-Rodríguez RU; Ruiz-Margáin A; Cantú-Brito C; Flores-Silva DF; García-Flores OR; Cubero FJ; Larrieta-Carrasco E; Torre A
    Liver Transpl; 2018 Dec; 24(12):1673-1679. PubMed ID: 30207422
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cognitive impairment and electroencephalographic alterations before and after liver transplantation: what is reversible?
    Campagna F; Montagnese S; Schiff S; Biancardi A; Mapelli D; Angeli P; Poci C; Cillo U; Merkel C; Gatta A; Amodio P
    Liver Transpl; 2014 Aug; 20(8):977-86. PubMed ID: 24809329
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cerebral magnetic resonance imaging reveals marked abnormalities of brain tissue density in patients with cirrhosis without overt hepatic encephalopathy.
    Guevara M; Baccaro ME; Gómez-Ansón B; Frisoni G; Testa C; Torre A; Molinuevo JL; Rami L; Pereira G; Sotil EU; Córdoba J; Arroyo V; Ginès P
    J Hepatol; 2011 Sep; 55(3):564-573. PubMed ID: 21163310
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association Between Portosystemic Shunts and Increased Complications and Mortality in Patients With Cirrhosis.
    Simón-Talero M; Roccarina D; Martínez J; Lampichler K; Baiges A; Low G; Llop E; Praktiknjo M; Maurer MH; Zipprich A; Triolo M; Vangrinsven G; Garcia-Martinez R; Dam A; Majumdar A; Picón C; Toth D; Darnell A; Abraldes JG; Lopez M; Kukuk G; Krag A; Bañares R; Laleman W; La Mura V; Ripoll C; Berzigotti A; Trebicka J; Calleja JL; Tandon P; Hernandez-Gea V; Reiberger T; Albillos A; Tsochatzis EA; Augustin S; Genescà J;
    Gastroenterology; 2018 May; 154(6):1694-1705.e4. PubMed ID: 29360462
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of common chronic medical conditions on psychometric tests used to diagnose minimal hepatic encephalopathy.
    Lauridsen MM; Poulsen L; Rasmussen CK; Høgild M; Nielsen MK; de Muckadell OB; Vilstrup H
    Metab Brain Dis; 2016 Apr; 31(2):267-72. PubMed ID: 26435407
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cognitive reserve is a determinant of health-related quality of life in patients with cirrhosis, independent of covert hepatic encephalopathy and model for end-stage liver disease score.
    Patel AV; Wade JB; Thacker LR; Sterling RK; Siddiqui MS; Stravitz RT; Sanyal AJ; Luketic V; Puri P; Fuchs M; Matherly S; White MB; Unser A; Heuman DM; Bajaj JS
    Clin Gastroenterol Hepatol; 2015 May; 13(5):987-91. PubMed ID: 25445772
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Validation of the psychometric hepatic encephalopathy score (PHES) for identifying patients with minimal hepatic encephalopathy.
    Duarte-Rojo A; Estradas J; Hernández-Ramos R; Ponce-de-León S; Córdoba J; Torre A
    Dig Dis Sci; 2011 Oct; 56(10):3014-23. PubMed ID: 21461913
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The psychomotor vigilance task: Role in the diagnosis of hepatic encephalopathy and relationship with driving ability.
    Formentin C; De Rui M; Zoncapè M; Ceccato S; Zarantonello L; Senzolo M; Burra P; Angeli P; Amodio P; Montagnese S
    J Hepatol; 2019 Apr; 70(4):648-657. PubMed ID: 30633946
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.